Cellular Biomedicine Group

136 articles about Cellular Biomedicine Group

• Cellular Biomedicine Group To Present Phase Iia Results From CAR-T CD20 Immuno-Oncology Clinical Development Program For Advanced Diffuse Large B Cell Lymphoma

  10/23/2015

• Cellular Biomedicine Group Responds To Inquiries From Investors And The Scientific Community About Its Immuno-Oncology Cell Therapy Platform

  9/28/2015

• Cellular Biomedicine Group Announces Positive Results From CAR-T EGFR Immunotherapy In Advanced Relapsed/Refractory Patients With Solid Tumors

  9/28/2015

• Cellular Biomedicine Group To Present CAR-T Phase I Clinical Trial Data For Non Small Cell Lung Cancer And Other Solid Tumors At 5th World Congress On Cancer Therapy

  9/16/2015

• Cellular Biomedicine Group To Release CAR-T For Non-Small Cell Lung Cancer Phase I Clinical Trial Data At 2015 European Cancer Congress

  9/14/2015

• Cellular Biomedicine Group Reports Second Quarter And First Half 2015 Financial Results And Business Highlights

  8/14/2015

• Cellular Biomedicine Group Appoints Former MedImmune/AstraZeneca PLC Senior Director, Yihong Yao, Ph.D., B.S., As Chief Scientific Officer

  8/11/2015

• Cellular Biomedicine Group To Present At The Inaugural Meeting Of Cartilage Repair And Applications Committee Of The Chinese Society For Biomaterials

  8/7/2015

• Cellular Biomedicine Group Announces Successful New Certifications For Proprietary Cell And Tissue Preservation Media Kits

  7/27/2015

• Cellular Biomedicine Group Appoints Alan List, MD As Chair Of Scientific Advisory Board

  7/8/2015

• Cellular Biomedicine Group Today Responded To The Class Action Lawsuit

  6/30/2015

• Cellular Biomedicine Group Completes Acquisition Of CD40LGVAX Vaccine

  6/29/2015

• EXCLUSIVE: Cellular Biomedicine Group Ready to Hire After Snapping Up Cancer Vaccine

  6/26/2015

• Cellular Biomedicine Group Selected For Inclusion In The Russell 3000 Index

  6/16/2015

• Cellular Biomedicine Group Enters Into Definitive Agreement To Acquire CD40LGVAX Vaccine And Related Technologies And Know-How Which Will Be Used In A Pending PD-1 Combination Clinical Trial In The U.S. For Non-Small Cell Lung Cancer (NSCLC)

  6/9/2015

• Cellular Biomedicine Group Announces Publication Of Human Adipose-Derived Progenitor Cells To Treat Knee Osteoarthritis

  6/5/2015

• Cellular Biomedicine Group To Provide Business And Clinical Updates At Jefferies and Co. 2015 Global Healthcare Conference

  5/29/2015

• Cellular Biomedicine Group Expands And Strengthens Leadership Team

  5/27/2015

• Cellular Biomedicine Group Announces Positive Phase I Results From CAR-T CD30 Immuno-Oncology Clinical Development Program

  5/22/2015

• Cellular Biomedicine Group Reports First Quarter 2015 Financial Results And Provides Business Highlights

  5/18/2015